Many Distinct Ways Lead to Drug Resistance in <i>BRAF</i>- and <i>NRAS</i>-Mutated Melanomas
Advanced melanoma is a relentless tumor with a high metastatic potential. The combat of melanoma by using the targeted therapy is impeded because several major driver mutations fuel its growth (predominantly <i>BRAF</i> and <i>NRAS</i>). Both these mutated oncogenes strongly...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/5/424 |